In addition, the HDAC inhibitor apicidin can diminish right ventricular hypertrophy and remodeling of pulmonary arteries by decreasing the activation of hypoxia-induced IGF-1/PaktS473 signaling pathway (Yang et al., 2015). The gene discussed is HDAC9; the disease is Right ventricular hypertrophy.